 | • レポートコード：QYR9N8122 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、胸腺がんのグローバル市場について調査・分析したレポートで、種類別（手術、放射線療法、化学療法、ターゲット療法）、用途別（病院、薬局、研究機関、製薬会社）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・胸腺がんの世界市場規模 ・主要企業別市場シェア ・胸腺がんの世界市場規模：種類別（手術、放射線療法、化学療法、ターゲット療法） ・胸腺がんの世界市場規模：用途別（病院、薬局、研究機関、製薬会社） ・胸腺がんのアメリカ市場規模（種類別、用途別） ・胸腺がんのヨーロッパ市場規模（種類別、用途別） ・胸腺がんの中国市場規模（種類別、用途別） ・胸腺がんの日本市場規模（種類別、用途別） ・胸腺がんの東南アジア市場規模（種類別、用途別） ・胸腺がんのインド市場規模（種類別、用途別） ・胸腺がんの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・胸腺がんの世界市場予測（2019年-2025年） ・胸腺がんの地域別市場予測（2019年-2025年） ... |
Thymus cancer or thyomas is a tumor formed on the outer surface of the thymus. Thymus is a small organ located in the upper chest under the breast bone and makes specific type of white blood cells which help the body fight infection.With increasing base of thyoma patients, the Thymus Cancer market is expected to have sizeable growth opportunity during the forecast period.
In 2018, the global Thymus Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Thymus Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thymus Cancer development in United States, Europe and China.
The key players covered in this study
Novartis International
Teva Pharmaceutical Industries
Bristol-Myers Squibb
Baxter Healthcare
Pfizer
Mylan
Sigma-Aldrich
Eli Lilly
Phyton Biotech
Market segment by Type, the product can be split into
Surgery
Radiation Therapy
Chemotherapy
Targeted Therapy
Market segment by Application, split into
Hospitals
Pharmacies
Research Organizations
Pharmaceutical Companies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Thymus Cancer status, future forecast, growth opportunity, key market and key players.
To present the Thymus Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Thymus Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Thymus Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Chemotherapy
1.4.5 Targeted Therapy
1.5 Market by Application
1.5.1 Global Thymus Cancer Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Pharmacies
1.5.4 Research Organizations
1.5.5 Pharmaceutical Companies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Thymus Cancer Market Size
2.2 Thymus Cancer Growth Trends by Regions
2.2.1 Thymus Cancer Market Size by Regions (2014-2025)
2.2.2 Thymus Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Thymus Cancer Market Size by Manufacturers
3.1.1 Global Thymus Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Thymus Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Thymus Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Thymus Cancer Key Players Head office and Area Served
3.3 Key Players Thymus Cancer Product/Solution/Service
3.4 Date of Enter into Thymus Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Thymus Cancer Market Size by Type (2014-2019)
4.2 Global Thymus Cancer Market Size by Application (2014-2019)
5 United States
5.1 United States Thymus Cancer Market Size (2014-2019)
5.2 Thymus Cancer Key Players in United States
5.3 United States Thymus Cancer Market Size by Type
5.4 United States Thymus Cancer Market Size by Application
6 Europe
6.1 Europe Thymus Cancer Market Size (2014-2019)
6.2 Thymus Cancer Key Players in Europe
6.3 Europe Thymus Cancer Market Size by Type
6.4 Europe Thymus Cancer Market Size by Application
7 China
7.1 China Thymus Cancer Market Size (2014-2019)
7.2 Thymus Cancer Key Players in China
7.3 China Thymus Cancer Market Size by Type
7.4 China Thymus Cancer Market Size by Application
8 Japan
8.1 Japan Thymus Cancer Market Size (2014-2019)
8.2 Thymus Cancer Key Players in Japan
8.3 Japan Thymus Cancer Market Size by Type
8.4 Japan Thymus Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Thymus Cancer Market Size (2014-2019)
9.2 Thymus Cancer Key Players in Southeast Asia
9.3 Southeast Asia Thymus Cancer Market Size by Type
9.4 Southeast Asia Thymus Cancer Market Size by Application
10 India
10.1 India Thymus Cancer Market Size (2014-2019)
10.2 Thymus Cancer Key Players in India
10.3 India Thymus Cancer Market Size by Type
10.4 India Thymus Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Thymus Cancer Market Size (2014-2019)
11.2 Thymus Cancer Key Players in Central & South America
11.3 Central & South America Thymus Cancer Market Size by Type
11.4 Central & South America Thymus Cancer Market Size by Application
12 International Players Profiles
12.1 Novartis International
12.1.1 Novartis International Company Details
12.1.2 Company Description and Business Overview
12.1.3 Thymus Cancer Introduction
12.1.4 Novartis International Revenue in Thymus Cancer Business (2014-2019)
12.1.5 Novartis International Recent Development
12.2 Teva Pharmaceutical Industries
12.2.1 Teva Pharmaceutical Industries Company Details
12.2.2 Company Description and Business Overview
12.2.3 Thymus Cancer Introduction
12.2.4 Teva Pharmaceutical Industries Revenue in Thymus Cancer Business (2014-2019)
12.2.5 Teva Pharmaceutical Industries Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Thymus Cancer Introduction
12.3.4 Bristol-Myers Squibb Revenue in Thymus Cancer Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Baxter Healthcare
12.4.1 Baxter Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Thymus Cancer Introduction
12.4.4 Baxter Healthcare Revenue in Thymus Cancer Business (2014-2019)
12.4.5 Baxter Healthcare Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Thymus Cancer Introduction
12.5.4 Pfizer Revenue in Thymus Cancer Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Mylan
12.6.1 Mylan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Thymus Cancer Introduction
12.6.4 Mylan Revenue in Thymus Cancer Business (2014-2019)
12.6.5 Mylan Recent Development
12.7 Sigma-Aldrich
12.7.1 Sigma-Aldrich Company Details
12.7.2 Company Description and Business Overview
12.7.3 Thymus Cancer Introduction
12.7.4 Sigma-Aldrich Revenue in Thymus Cancer Business (2014-2019)
12.7.5 Sigma-Aldrich Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Company Details
12.8.2 Company Description and Business Overview
12.8.3 Thymus Cancer Introduction
12.8.4 Eli Lilly Revenue in Thymus Cancer Business (2014-2019)
12.8.5 Eli Lilly Recent Development
12.9 Phyton Biotech
12.9.1 Phyton Biotech Company Details
12.9.2 Company Description and Business Overview
12.9.3 Thymus Cancer Introduction
12.9.4 Phyton Biotech Revenue in Thymus Cancer Business (2014-2019)
12.9.5 Phyton Biotech Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Thymus Cancer Key Market Segments
Table Key Players Thymus Cancer Covered
Table Global Thymus Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Thymus Cancer Market Size Market Share by Type 2014-2025
Figure Surgery Figures
Table Key Players of Surgery
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Table Global Thymus Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Pharmacies Case Studies
Figure Research Organizations Case Studies
Figure Pharmaceutical Companies Case Studies
Figure Thymus Cancer Report Years Considered
Table Global Thymus Cancer Market Size 2014-2025 (Million US$)
Figure Global Thymus Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Thymus Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Thymus Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Thymus Cancer Market Share by Regions 2014-2019
Figure Global Thymus Cancer Market Share by Regions 2014-2019
Figure Global Thymus Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Thymus Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Thymus Cancer Market Share by Manufacturers (2014-2019)
Figure Global Thymus Cancer Market Share by Manufacturers in 2018
Table Global Thymus Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Thymus Cancer Product/Solution/Service
Table Date of Enter into Thymus Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Thymus Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Thymus Cancer Market Size Share by Type (2014-2019)
Figure Global Thymus Cancer Market Size Market Share by Type (2014-2019)
Table Global Thymus Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Thymus Cancer Market Size Share by Application (2014-2019)
Figure Global Thymus Cancer Market Size Market Share by Application (2014-2019)
Figure Global Thymus Cancer Revenue Market Share by Application in 2018
Figure United States Thymus Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Thymus Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Thymus Cancer Market Share (2018-2019)
Table United States Thymus Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Thymus Cancer Market Share by Type (2014-2019)
Table United States Thymus Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Thymus Cancer Market Share by Application (2014-2019)
Figure Europe Thymus Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Thymus Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Thymus Cancer Market Share (2018-2019)
Table Europe Thymus Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Thymus Cancer Market Share by Type (2014-2019)
Table Europe Thymus Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Thymus Cancer Market Share by Application (2014-2019)
Figure China Thymus Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Thymus Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Thymus Cancer Market Share (2018-2019)
Table China Thymus Cancer Market Size by Type (2014-20189) (Million US$)
Table China Thymus Cancer Market Share by Type (2014-2019)
Table China Thymus Cancer Market Size by Application (2014-2019) (Million US$)
Table China Thymus Cancer Market Share by Application (2014-2019)
Figure Japan Thymus Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Thymus Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Thymus Cancer Market Share (2018-2019)
Table Japan Thymus Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Thymus Cancer Market Share by Type (2014-2019)
Table Japan Thymus Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Thymus Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Thymus Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Thymus Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Thymus Cancer Market Share (2018-2019)
Table Southeast Asia Thymus Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Thymus Cancer Market Share by Type (2014-2019)
Table Southeast Asia Thymus Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Thymus Cancer Market Share by Application (2014-2019)
Figure India Thymus Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Thymus Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Thymus Cancer Market Share (2018-2019)
Table India Thymus Cancer Market Size by Type (2014-2019) (Million US$)
Table India Thymus Cancer Market Share by Type (2014-2019)
Table India Thymus Cancer Market Size by Application (2014-2019) (Million US$)
Table India Thymus Cancer Market Share by Application (2014-2019)
Figure Central & South America Thymus Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Thymus Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Thymus Cancer Market Share (2018-2019)
Table Central & South America Thymus Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Thymus Cancer Market Share by Type (2014-2019)
Table Central & South America Thymus Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Thymus Cancer Market Share by Application (2014-2019)
Table Novartis International Company Details
Table Novartis International Revenue in Thymus Cancer Business (2014-2019) (Million US$)
Figure Novartis International Revenue Growth Rate in Thymus Cancer Business (2014-2019)
Table Novartis International Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Thymus Cancer Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Thymus Cancer Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Thymus Cancer Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Thymus Cancer Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Baxter Healthcare Company Details
Table Baxter Healthcare Revenue in Thymus Cancer Business (2014-2019)(Million US$)
Figure Baxter Healthcare Revenue Growth Rate in Thymus Cancer Business (2014-2019)
Table Baxter Healthcare Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Thymus Cancer Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Thymus Cancer Business (2014-2019)
Table Pfizer Recent Development
Table Mylan Company Details
Table Mylan Revenue in Thymus Cancer Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Thymus Cancer Business (2014-2019)
Table Mylan Recent Development
Table Sigma-Aldrich Company Details
Table Sigma-Aldrich Revenue in Thymus Cancer Business (2014-2019)(Million US$)
Figure Sigma-Aldrich Revenue Growth Rate in Thymus Cancer Business (2014-2019)
Table Sigma-Aldrich Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Thymus Cancer Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Thymus Cancer Business (2014-2019)
Table Eli Lilly Recent Development
Table Phyton Biotech Company Details
Table Phyton Biotech Revenue in Thymus Cancer Business (2014-2019)(Million US$)
Figure Phyton Biotech Revenue Growth Rate in Thymus Cancer Business (2014-2019)
Table Phyton Biotech Recent Development
Table Global Thymus Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Thymus Cancer Market Size Share by Regions (2019-2025)
Figure Global Thymus Cancer Market Size Share by Regions in 2025
Figure United States Thymus Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Thymus Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Thymus Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Thymus Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Thymus Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Thymus Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Thymus Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Thymus Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Thymus Cancer Market Size by Product (2019-2025)
Figure Global Thymus Cancer Market Size by Product in 2025
Table Global Thymus Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Thymus Cancer Market Size by Application (2019-2025)
Figure Global Thymus Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…- 世界の白血病がん市場：市場規模・現状・予測 Leukemia is a group ofcancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. High incidence rate of blood cancers and rise in incidence of leukaemia across the globe will drive the leukemia market. In 2018, the global Leukemia Cancer market size was x…
- 世界の非血液がん治療市場：市場規模・現状・予測 Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.North America has the huge number of population suffering fro…
- 世界の非黒色腫皮膚がんの治療市場：市場規模・現状・予測 Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikel…
- 世界の精密がん治療市場：市場規模・現状・予測 Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalit…